• SUBSCRIBE
    • Action Alerts PLUS
    • Real Money
    • Real Money Pro
    • Quant Ratings
    • Retirement Daily
    • Stocks Under $10
    • Trifecta Stocks
    • Top Stocks
    • Real Money Pro Portfolio
    • Chairman's Club
    • Compare All
  • JIM CRAMER
    • Action Alerts PLUS
    • Cramer's Blog
    • Cramer's Monthly Call
    • Jim Cramer's Best Stocks
    • Cramer's Articles
    • Mad Money
    • 25 Rules for Investing
    • 10 Commandments
  • INVESTING
    • Bitcoin
    • Cannabis
    • Cryptocurrency
    • ETFs
    • Earnings
    • Fixed Income
    • Funds
      • Bond Funds
      • Index Funds
      • Mutual Funds
    • Futures
    • Options
    • REITs
    • Stocks
      • Penny Stocks
      • Preferred Stocks
  • PERSONAL FINANCE
    • Credit Cards
    • Debt Management
    • Education
    • Employee Benefits
    • Insurance
      • Car Insurance
      • Disability Insurance
      • Health Insurance
      • Home Insurance
      • Life Insurance
    • Mortgages
    • Real Estate
    • Savings
    • Taxes
  • RETIREMENT
    • 401K
    • Estate Planning
    • IRAs
      • Roth IRAs
    • Social Security
  • TECHNOLOGY
    • Cybersecurity
  • MARKETS
    • Bankruptcy
    • Commodities
      • Gold
      • Oil
    • Corporate Governance
    • Currencies
    • Emerging Markets
    • IPOs
    • Mergers and Acquisitions
    • Rates and Bonds
      • Junk Bonds
      • Treasury Bonds
    • Regulation
  • HOW-TO
  • VIDEO
    • Audio
  • Courses
    • Personal Finance Essentials
    • Fundamentals of Investing
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
  • Privacy Settings
Logo
  • JIM CRAMER
  • INVESTING
  • PERSONAL FINANCE
  • RETIREMENT
  • TECHNOLOGY
  • MARKETS
  • HOW-TO
  • VIDEO
  • COURSES
Login
Account
TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
  • Alerts
  • |
  • Newsletters
Logo
  • JIM CRAMER
  • INVESTING
  • PERSONAL FINANCE
  • RETIREMENT
  • TECHNOLOGY
  • MARKETS
  • HOW-TO
  • VIDEO
  • COURSES
Login
Account

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

3 Cutting-Edge Biotech Stocks That Can Double in Value
STOCKS

15 Biotech Firms That Have Strong Potential to Be Acquired: Jefferies

  • By Kinsey Grant
  • Mar 20, 2018 2:58 PM EDT
3 Cutting-Edge Biotech Stocks That Can Double in Value
MERGERS AND ACQUISITIONS

Why 2018 will be better for biotech deals than 2017

  • By Armie Margaret Lee
  • Jan 25, 2018 7:15 PM EST
Mesoblast Soars on Stem-Cell Treatment Data
STOCKS

FDA OKs BioCryst's Rapivab for Pediatric Indication - Biotech Movers

  • By Armie Margaret Lee
  • Sep 21, 2017 10:10 AM EDT
Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
HEALTH

Biotech Movers: BioCryst, Omeros, Radius Health

  • By Armie Margaret Lee
  • Jul 3, 2017 9:24 AM EDT
Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
HEALTH

Biotech Movers: Loxo, NewLink, BioCryst

  • By Armie Margaret Lee
  • Jun 5, 2017 9:25 AM EDT
Biotech Movers: Lion Biotechnologies, XBiotech, Halozyme
HEALTH

Biotech Movers: Positive Phase Three Results For Roclatan Send Aerie Shares Soaring

  • By Armie Margaret Lee
  • May 25, 2017 9:37 AM EDT
Mesoblast Soars on Stem-Cell Treatment Data
HEALTH

Biotech Premarket Movers: Esperion, Minerva and BioCryst

  • By Armie Margaret Lee
  • Mar 21, 2017 9:32 AM EDT
Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
HEALTH

Biotech Premarket Movers: Spectrum, BioCryst, Curis

  • By Armie Margaret Lee
  • Mar 9, 2017 10:07 AM EST
Everything We Know About BioCryst's New HAE Drug
VIDEO

Everything We Know About BioCryst's New HAE Drug

  • By TheStreet Staff
  • Feb 27, 2017 10:56 AM EST
BioCryst Pill Prevents Swelling Attacks but Shares Fall on Competitive Concerns
STOCKS

BioCryst pill prevents swelling attacks but shares fall on competitive concerns

  • By Adam Feuerstein
  • Feb 27, 2017 10:02 AM EST
Biotech Movers: Lion Biotechnologies, XBiotech, Halozyme
HEALTH

Biotech premarket movers: Biocryst, Sangamo, Cempra

  • By Armie Margaret Lee
  • Feb 27, 2017 9:09 AM EST
Innoviva Says It Fends Off Sarissa Dissidents
STOCKS

BioCryst Pharmaceuticals Drops After Reporting 4Q Loss

  • By Tony Owusu
  • Feb 27, 2017 7:51 AM EST
Biotech Movers: Lion Biotechnologies, XBiotech, Halozyme
STOCKS

Biotech premarket movers: Progenics, Alexion, BioCryst

  • By Armie Margaret Lee
  • Feb 16, 2017 9:52 AM EST
Biotech Movers: Lion Biotechnologies, XBiotech, Halozyme
HEALTH

Premarket biotech movers: Synergy, Arrowhead, BioCryst

  • By Armie Margaret Lee
  • Feb 1, 2017 9:23 AM EST
Dry Bulk Shippers Upgraded at Morgan Stanley, Stocks Surge
OPINION

8 stocks under $10 to trade for huge profits

  • By Roberto Pedone
  • Jul 29, 2016 6:59 AM EDT
Energy Transfer Equity (ETE) Is Today's Dead Cat Bounce Stock
MARKETS

Biocryst Pharmaceuticals (BCRX) Is Today's Strong On High Volume Stock

  • By TheStreet Wire
  • Jun 7, 2016 10:01 AM EDT
Today's Weak On High Volume Stock: Spirit AeroSystems Holdings (SPR)
MARKETS

Trade-Ideas: Biocryst Pharmaceuticals (BCRX) Is Today's Weak On High Relative Volume Stock

  • By TheStreet Wire
  • May 5, 2016 10:01 AM EDT
Barbarian At The Gate: Annaly Capital Management (NLY)
MARKETS

Biocryst Pharmaceuticals (BCRX) Stock: Weak On High Volume Today

  • By TheStreet Wire
  • Apr 26, 2016 10:08 AM EDT
Today's Weak On High Volume Stock: Primero Mining (PPP)
MARKETS

Strong On High Volume: Biocryst Pharmaceuticals (BCRX)

  • By TheStreet Wire
  • Apr 21, 2016 10:04 AM EDT
TrueCar Posts Another 1Q Loss, With In-Line Revenue
OPINION

These 7 stocks under $10 are making big moves to the upside

  • By Roberto Pedone
  • Apr 15, 2016 7:59 AM EDT
Global Blood Therapeutics Stock Surging on Nordisk Bid Speculation
OPINION

These 5 under-$10 biotech stocks are about to break out

  • By Roberto Pedone
  • Apr 1, 2016 7:02 AM EDT
JPMorgan’s Top 4 Oversold Pharma Stocks for Patient Investors
MERGERS AND ACQUISITIONS

Valeant's great fall puts focus on Chairman Ingram and his many hats

  • By Ronald Orol
  • Mar 17, 2016 11:11 AM EDT
Trade-Ideas: Marvell Technology Group (MRVL) Is Today's Post-Market Leader Stock
MARKETS

Biocryst Pharmaceuticals (BCRX) Stock: Weak On High Volume Today

  • By TheStreet Wire
  • Mar 8, 2016 10:01 AM EST
PTC Therapeutics (PTCT) Stock Upgraded at Jefferies
MARKETS

Here's Why BioCryst Pharmaceuticals (BCRX) Stock is Spiking Today

  • By Kaya Yurieff
  • Mar 7, 2016 2:25 PM EST
Biotech movers: CEL-SCI Leaps After FDA Lets Cancer Study Move Forward
OPINION

5 stocks poised for breakouts

  • By Roberto Pedone
  • Feb 26, 2016 8:54 AM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2019 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.